Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

glenmark arzneimittel gmbh - zonisamid - kapsler, hårde - 100 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

glenmark arzneimittel gmbh - zonisamid - kapsler, hårde - 25 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

glenmark arzneimittel gmbh - zonisamid - kapsler, hårde - 50 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - adrenalin - injektionsvæske, opløsning - 0,15 mg/dosis

Den Europæiske Union - dansk - EMA (European Medicines Agency)

alnylam netherlands b.v. - patisiran natrium - amyloidose, familiær - andre narkotika stoffer - onpattro er indiceret til behandling af arvelige transthyretin-medieret amyloidose (hattr amyloidose) hos voksne patienter med fase 1 eller fase 2 polyneuropati.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - andre antineoplastiske midler - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastiske midler - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - adrenalintartrat - injektionsvæske, opløsning - 1 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

ethypharm - adrenalintartrat - injektionsvæske, opløsning - 1 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - adrenalintartrat - injektionsvæske, opløsning - 1 mg/ml